MBCOF (Marvel Biosciences) EPS (Basic): $-0.03 (TTM As of Apr. 2026)


MBCOF Marvel Biosciences Corp MBCOF
33 GF Score
Price $0.12
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences EPS (Basic)?

Marvel Biosciences MBCOF +4.74% 33 EPS (Basic) is $-0.03 as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review.

Marvel Biosciences's basic earnings per share (Basic EPS) for the three months ended in Apr. 2026 was $0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.03.

Marvel Biosciences's EPS (Diluted) for the three months ended in Apr. 2026 was $0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.03.

Marvel Biosciences's EPS without NRI for the three months ended in Apr. 2026 was $0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2026 was -0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Marvel Biosciences  (OTCPK:MBCOF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Marvel Biosciences EPS (Basic) Related Terms

Marvel Biosciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences EPS (Basic) Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
EPS (Basic)
Get a 7-Day Free Trial -0.14 -0.06 -0.05 -0.03 -0.04

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 -0.01 -0.01 0.01
MBCOF
33GF Score
Marvel Biosciences Corp MBCOF
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Marvel Biosciences's Basic EPS for the fiscal year that ended in Jul. 2025 is calculated as

Basic EPS (A: Jul. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.615-0)/47.305
=-0.03

Marvel Biosciences's Basic EPS for the quarter that ended in Apr. 2026 is calculated as

Basic EPS (Q: Apr. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.318-0)/61.561
=0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.03 mean?
Marvel Biosciences (MBCOF) has a EPS (Basic) of $-0.03 as of Apr. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Marvel Biosciences and its competitors.
Is Marvel Biosciences' EPS (Basic) too high?
Marvel Biosciences' current EPS (Basic) is $-0.03. Overall, Marvel Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' EPS (Basic) compare to VRTX and REGN?
Marvel Biosciences' EPS (Basic) of $-0.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Marvel Biosciences and its competitors. Marvel Biosciences's current EPS (Basic) is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current EPS (Basic) of $-0.03. The current EPS (Basic) is $-0.03. Marvel Biosciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current EPS (Basic) is $-0.03 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
33GF Score

Get the complete analysis for MBCOF

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price